MedTech founders often treat regulation as a hurdle. Malte instead argues it's one of your biggest strategic advantages. In this episode, we cover why regulatory planning should start at ideation, how intended purpose functions as a company-wide strategic tool, and why defining commercial claims lat

In this episode of the GS MedTech Podcast, we sat down with Alan Lucas, CEO of EnlightenVue and co-founder of Navigation Sciences, to discuss the micro-endoscope redefining minimally invasive biliary surgery. Alan shared how he is running two MedTech startups within a shared ecosystem, his approach

Filip Peters, founder and CEO of Acori Medical, joins the GS MedTech Podcast to discuss how his Swedish MedTech startup is redefining hemodynamic monitoring in heart failure care. We cover how Acori's non-invasive SAVE sensor platform estimates intracardiac pressure without catheterization, the resu

Is EVAR fixation failure the most expensive unsolved problem in vascular surgery? Joseph Rafferty, CEO of Vesteck, joins the GS MedTech Podcast to discuss Suture-Tight - a catheter-based platform designed to mechanically secure endovascular grafts and permanently address migration and endoleaks. We

From a landmark stroke patient who recovered beyond all clinical expectations, to closed-loop brain-computer interfaces that listen and respond to the brain in real time - CorTec is challenging decades of assumptions about what's possible in neurological care. Frank Desiere, CEO of CorTec, joined us

Tresquare Technologies is pioneering a new approach to TAVI-in-TAVI procedures for degenerated aortic bioprostheses. Its platform is designed to mechanically resect and remove calcified leaflets before a transcatheter valve is implanted, a potential game-changer in improving haemodynamic outcomes an

Why has the synthetic meniscus been called MedTech's "holy grail"? ATRO Medical's new CEO Maarten van der Zanden explains what makes the Artimis artificial meniscus prosthesis different. Backed by a fresh €3M round, ATRO is now preparing for pivotal studies in the US and Europe. Learn more about the

Phil Kemp, President & Chief Operating Office at X-Bolt Orthopedics sat down with Dame to share how he's building a next-generation fixation platform after years at Stryker. From navigating the $50K cost of hip fracture failure to scaling trust before revenue, Phil reveals what it takes to solve ort

We sat down with Declan Soden, CEO at Mirai Medical, who shared how pulsed electric field technology is transforming GI cancer treatment with zero adverse events in 100 patients. He shares details about efficiently raising €30M, building the right team, navigating oncology adoption barriers, and sca

In this episode of the GS MedTech Podcast, we sit down with Niklas Green, Head of Invesdor Nordics, to explore one of the most misunderstood funding routes in MedTech - crowdfunding. If you are trying to navigate your next funding round, this episode will answer the questions you should be asking. F